About Axio Biosolutions Private Limited
Data last updated:
Axio Biosolutions Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Advamedica Inc and recognised as a startup by DPIIT. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 16 May 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U73100GJ2008PTC053905. Its GSTIN is 24AAHCA0497M1ZF (Gujarat). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.71 Cr. It is led by directors Gourav Jagdishchandra Maheshwari and Leo Sebastian Mavely.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 18 Gujarat Pharma Techno Park Sari – Motoda Ta: Sanand, Ahmedabad, Gujarat, India – 382220.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.9 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹2.71 Cr (net margin -13.6%) and EBITDA of -₹1.89 Cr (EBITDA margin -9.5%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 14% over five years.
The company has about 70 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: AxioBio. As per MCA filings, the company has open charges of ₹7.84 Cr and satisfied charges of ₹10.26 Cr on record. Court records list 4 cases involving the company, including 4 filed against it; 1 case is pending. The company has 11 deals on record (8 funding rounds, 3 secondary share transfers), with disclosed funding of ₹60.88 Cr; the latest was in October 2021.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website axiobio.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No 18 Gujarat Pharma Techno Park Sari – Motoda Ta: Sanand, Ahmedabad, Gujarat, India – 382220
- IndustryHealthcare, Medical Consumables & Supplies
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Axio Biosolutions Private Limited
The main business activities of Axio Biosolutions are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Axio Biosolutions Private Limited FY 2024 filings available
Axio Biosolutions Private Limited reported revenue of ₹19.9 Cr (down 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Axio Biosolutions Private Limited
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Axio Biosolutions Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.89 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.71 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Axio Biosolutions Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -13.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Axio Biosolutions are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Axio Biosolutions Private Limited
Axio Biosolutions Private Limited is audited by S.R. BATLIBOI & ASSOCIATES LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.R. BATLIBOI & ASSOCIATES LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Axio Biosolutions Private Limited
Axio Biosolutions has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gourav Jagdishchandra Maheshwari | Director | 16 May 2018 | 8 Years 4 Months | Current |
| Leo Sebastian Mavely Also directs: Leyam Enterprises LLP | Director | 16 May 2008 | 18 Years 4 Months | Current |
Ownership and Shareholding of Axio Biosolutions Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Axio Biosolutions Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2023 | Others | ₹7.84 Cr | Satisfied |
| 18 Oct 2013 | Technology Development Board | ₹1.33 Cr | Satisfied |
| 28 Jun 2010 | Gvfl Trustee Company Private Limited | ₹1.09 Cr | Satisfied |
Total charge records: 3 View all charges
Deals & Funding of Axio Biosolutions Private Limited
Axio Biosolutions Private Limited has 11 deals on record (8 funding rounds, 3 secondary share transfers), with disclosed funding of ₹60.88 Cr; the latest was in October 2021.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2021 | Funding round | ₹22.05 Cr | Investors: Advamedica Inc |
| Feb 2020 | Funding round | ₹17.71 Cr | Investors: Advamedica Inc |
| Sep 2018 | Funding round | ₹10.8 Cr | Investors: Advamedica Inc |
| Jun 2016 | Secondary share transfer | Undisclosed | Seller: Advamedica Inc |
| May 2016 | Secondary share transfer | Undisclosed | Buyer: Advamedica Inc Seller: GVFL, 3 individuals |
Full deal history
All 11 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Axio Biosolutions Private Limited
Axio Biosolutions Private Limited has 4 court cases on record: 4 filed against it. 1 case is pending and 3 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed against the company by Shoogloo Network Private Limited | Disposed |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by an individual | Pending |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed against the company by an individual | Disposed |
| District court, South East, Delhi | Commercial suit | Filed against the company by an individual | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Axio Biosolutions Private Limited
Axio Biosolutions operates one associated brand: AxioBio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of advanced haemostat and wound care dressing products | axiobio.com |
Employees and EPFO Compliance at Axio Biosolutions Private Limited
Axio Biosolutions Private Limited has a workforce of 70 employees as of Feb 24, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Axio Biosolutions Private Limited
Recent Activity on Axio Biosolutions Private Limited
Axio Biosolutions Private Limited has 9 board changes on record since 2008: 2 appointments and 7 cessations. The latest: Sebastian Joseph Mavely ceased to be Director on 26 Aug 2019.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Axio Biosolutions Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Axio Biosolutions Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Axio Biosolutions Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Axio Biosolutions Private Limited
Axio Biosolutions has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCA0497M1ZF | Gujarat | Active | 01 Jul 2017 |
| 29AAHCA0497M2Z4 | Karnataka | Active | 13 Jul 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Axio Biosolutions Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axio Biosolutions Private Limited
Axio Biosolutions is an active private limited company based in Ahmedabad, Gujarat, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 16 May 2008 (18+ years old) and is registered under CIN U73100GJ2008PTC053905.
Axio Biosolutions reported revenue of ₹19.9 Cr for FY 2024 (down 17% YoY).
Axio Biosolutions has 2 current directors:
- Gourav Jagdishchandra Maheshwari - Director
- Leo Sebastian Mavely - Director
Axio Biosolutions reported a net loss of ₹2.71 Cr (net margin -13.6%) and EBITDA of -₹1.89 Cr (EBITDA margin -9.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Axio Biosolutions is 15% over three years and 14% over five years. In the latest year (FY 2024) revenue fell 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Axio Biosolutions is 24AAHCA0497M1ZF, registered in Gujarat. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 29AAHCA0497M2Z4 (Karnataka).
The CIN (Corporate Identification Number) of Axio Biosolutions is U73100GJ2008PTC053905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axio Biosolutions has 4 court cases on record: 4 filed against it. 1 is pending.
Axio Biosolutions was incorporated on 16 May 2008, making it 18+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Axio Biosolutions has 11 deals on record (8 funding rounds, 3 secondary share transfers), with disclosed funding of ₹60.88 Cr; the latest was in October 2021.